Mictonet (Propiverine Hydrochloride)

Propiverine is an antimuscarinic that blocks muscarinic (M2 and M3) receptors on the detrusor muscle, decreasing acetylcholine‑driven contractions. This action reduces involuntary bladder spasms and increases functional bladder capacity, relieving overactive bladder symptoms.

The dosage of Mictonet is determined by the prescribing healthcare professional based on the individual patient's condition, age, renal and hepatic function, and response to therapy. The prescriber will select the appropriate strength and regimen according to clinical guidelines.

Safety of propiverine in pregnancy and lactation has not been established. It should be used only if the potential therapeutic benefit justifies the potential risk to the fetus or infant, and only under close medical supervision.

To place an order, submit an enquiry on the Mictonet product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mictonet (propiverine) shares the antimuscarinic mechanism with agents such as oxybutynin and tolterodine, but it may offer a longer duration of action and a distinct side‑effect profile. Choice among these agents depends on individual patient response, tolerability and physician assessment.

Mictonet tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and do not use after the expiry date indicated on the label.

Mictonet is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional. Follow the prescriber’s directions regarding timing relative to meals.

Serious adverse reactions can include urinary retention, severe allergic responses such as anaphylaxis, and angle‑closure glaucoma. Patients should seek immediate medical attention if they experience difficulty urinating, swelling of the face or throat, or sudden visual disturbances.

Mictonet is contraindicated in individuals with known hypersensitivity to propiverine or other antimuscarinic agents, patients with uncontrolled narrow‑angle glaucoma, and those with existing urinary retention. Caution is also advised for patients with severe renal or hepatic impairment.